Daniel Pereira
About Daniel Pereira
Daniel Pereira serves as the Chief Scientific Officer at Invenra in Madison, Wisconsin, a position he has held since 2022. He has extensive experience in the biotechnology and pharmaceutical sectors, having previously worked in various leadership roles at notable companies such as ImClone Systems, Arch Oncology, and Astellas Pharma.
Work at Invenra
Daniel Pereira has served as the Chief Scientific Officer at Invenra since 2022. In this role, he is responsible for overseeing the scientific direction and research initiatives of the company. Invenra is based in Madison, Wisconsin, and focuses on developing innovative therapeutic solutions.
Previous Experience in Oncology and Research
Prior to his current position, Pereira held several significant roles in the biotechnology and pharmaceutical sectors. He was the Chief Scientific Officer at Arch Oncology from 2018 to 2021. Before that, he worked at Astellas Pharma US as Vice President of Discovery Research at Agensys Inc. from 2011 to 2017, and at Roche as Vice President and Research Site Head from 2006 to 2010.
Background in Tumor Biology
Daniel Pereira has a strong background in tumor biology, having served as Director of Tumor Biology at ImClone Systems from 1998 to 2006. His work at ImClone, a subsidiary of Eli Lilly and Company, contributed to advancements in cancer research and treatment.
Education and Expertise
Pereira earned his Doctor of Philosophy (PhD) from McMaster University, where he studied from 1991 to 1996. His academic training laid the foundation for his extensive career in scientific research and leadership within the biotechnology industry.
Postdoctoral Research Experience
Before entering the corporate sector, Pereira completed a postdoctoral fellowship at The Hospital for Sick Children in Toronto, Ontario, Canada. He worked in the John Dick Laboratory from 1996 to 1998, focusing on research that contributed to the understanding of cancer biology.